True Link Financial Advisors, LLC Bristol Myers Squibb CO Transaction History

True Link Financial Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	BUY	$72.62 - $79.98 $194,258 - $213,946	2,675 New	2,675 $206,000
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $164,459 - $197,201	-2,675 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$53.63 - $62.52 $3,164 - $3,688	-59 Reduced 2.16%	2,675 $167,000
Q3 2021 Oct 29, 2021	BUY	$59.17 - $69.31 $71,004 - $83,172	1,200 Added 78.23%	2,734 $162,000
Q2 2021 Aug 19, 2021	BUY	$61.91 - $67.42 $3,652 - $3,977	59 Added 4.0%	1,534 $103,000
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $85,166 - $96,509	1,475 New	1,475 $91,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of True Link Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on True Link Financial Advisors, LLC with notifications on news.